ID   F91A1_HUMAN             Reviewed;         838 AA.
AC   Q658Y4; B6YY23; Q658T5; Q8TE89;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 3.
DT   07-APR-2021, entry version 126.
DE   RecName: Full=Protein FAM91A1;
GN   Name=FAM91A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT TYR-800.
RA   Nicassio F., Bianchi F., Capra M., Vecchi M., Confalonieri S., Bianchi M.,
RA   Pajalunga D., Crescenzi M., Bonapace I.M., Di Fiore P.P.;
RT   "A cancer-specific transcriptional signature in human neoplasia.";
RL   Eur. J. Clin. Invest. 115:0-0(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 144-838, AND VARIANT TYR-800.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 336-838, AND VARIANT TYR-800.
RC   TISSUE=Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340 AND SER-671, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-671, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332 AND SER-828, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-671, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   INTERACTION WITH GOLGA1; GOLGA4 AND TBC1D23, AND SUBCELLULAR LOCATION.
RX   PubMed=29084197; DOI=10.1038/ncb3627;
RA   Shin J.J.H., Gillingham A.K., Begum F., Chadwick J., Munro S.;
RT   "TBC1D23 is a bridging factor for endosomal vesicle capture by golgins at
RT   the trans-Golgi.";
RL   Nat. Cell Biol. 19:1424-1432(2017).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH
RP   C17ORF75 AND WDR11.
RX   PubMed=29426865; DOI=10.1038/s41467-018-02919-4;
RA   Navarro Negredo P., Edgar J.R., Manna P.T., Antrobus R., Robinson M.S.;
RT   "The WDR11 complex facilitates the tethering of AP-1-derived vesicles.";
RL   Nat. Commun. 9:596-596(2018).
CC   -!- FUNCTION: As component of the WDR11 complex acts together with TBC1D23
CC       to facilitate the golgin-mediated capture of vesicles generated using
CC       AP-1. {ECO:0000269|PubMed:29426865}.
CC   -!- SUBUNIT: Component of the complex WDR11 composed of C17orf75, FAM91A1
CC       and WDR11; FAM91A1 and WDR11 are required for proper location of the
CC       complex (PubMed:29426865). Interacts with golgins GOLGA1 and GOLGA4 and
CC       with TBC1D23; interaction with golgins may be mediated by TBC1D23 and
CC       interaction with TBC1D23 recruits TBC1D23 to AP-1-derived vesicles
CC       (PubMed:29084197, PubMed:29426865). {ECO:0000269|PubMed:29084197,
CC       ECO:0000269|PubMed:29426865}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network
CC       {ECO:0000269|PubMed:29084197, ECO:0000269|PubMed:29426865}. Cytoplasmic
CC       vesicle {ECO:0000269|PubMed:29426865}. Note=Recruitment to the TGN
CC       requires the presence of GOLGA1, GOLGA4 and TBC1D23.
CC       {ECO:0000269|PubMed:29084197}.
CC   -!- SIMILARITY: Belongs to the FAM91 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB85063.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ228141; ABB17070.1; -; mRNA.
DR   EMBL; AC011134; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK074370; BAB85063.1; ALT_INIT; mRNA.
DR   EMBL; AL832830; CAH56231.1; -; mRNA.
DR   EMBL; AL832999; CAH56297.1; -; mRNA.
DR   CCDS; CCDS6346.2; -.
DR   RefSeq; NP_001304846.1; NM_001317917.1.
DR   RefSeq; NP_001304847.1; NM_001317918.1.
DR   RefSeq; NP_659400.2; NM_144963.3.
DR   BioGRID; 127622; 49.
DR   IntAct; Q658Y4; 22.
DR   MINT; Q658Y4; -.
DR   STRING; 9606.ENSP00000335082; -.
DR   iPTMnet; Q658Y4; -.
DR   PhosphoSitePlus; Q658Y4; -.
DR   BioMuta; FAM91A1; -.
DR   DMDM; 212276508; -.
DR   EPD; Q658Y4; -.
DR   jPOST; Q658Y4; -.
DR   MassIVE; Q658Y4; -.
DR   MaxQB; Q658Y4; -.
DR   PaxDb; Q658Y4; -.
DR   PeptideAtlas; Q658Y4; -.
DR   PRIDE; Q658Y4; -.
DR   ProteomicsDB; 65930; -.
DR   Antibodypedia; 27033; 116 antibodies.
DR   DNASU; 157769; -.
DR   Ensembl; ENST00000334705; ENSP00000335082; ENSG00000176853.
DR   GeneID; 157769; -.
DR   KEGG; hsa:157769; -.
DR   UCSC; uc003yqv.4; human.
DR   CTD; 157769; -.
DR   GeneCards; FAM91A1; -.
DR   HGNC; HGNC:26306; FAM91A1.
DR   HPA; ENSG00000176853; Low tissue specificity.
DR   neXtProt; NX_Q658Y4; -.
DR   OpenTargets; ENSG00000176853; -.
DR   PharmGKB; PA142671820; -.
DR   VEuPathDB; HostDB:ENSG00000176853.15; -.
DR   eggNOG; KOG3707; Eukaryota.
DR   GeneTree; ENSGT00390000009543; -.
DR   InParanoid; Q658Y4; -.
DR   OMA; SMGVHKA; -.
DR   OrthoDB; 164905at2759; -.
DR   PhylomeDB; Q658Y4; -.
DR   TreeFam; TF314641; -.
DR   PathwayCommons; Q658Y4; -.
DR   BioGRID-ORCS; 157769; 136 hits in 969 CRISPR screens.
DR   ChiTaRS; FAM91A1; human.
DR   GenomeRNAi; 157769; -.
DR   Pharos; Q658Y4; Tdark.
DR   PRO; PR:Q658Y4; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q658Y4; protein.
DR   Bgee; ENSG00000176853; Expressed in bone marrow and 209 other tissues.
DR   ExpressionAtlas; Q658Y4; baseline and differential.
DR   Genevisible; Q658Y4; HS.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0099041; P:vesicle tethering to Golgi; IDA:UniProtKB.
DR   InterPro; IPR039199; FAM91.
DR   InterPro; IPR028097; FAM91_C_dom.
DR   InterPro; IPR028091; FAM91_N_dom.
DR   PANTHER; PTHR28441; PTHR28441; 1.
DR   Pfam; PF14648; FAM91_C; 1.
DR   Pfam; PF14647; FAM91_N; 1.
PE   1: Evidence at protein level;
KW   Cytoplasmic vesicle; Golgi apparatus; Phosphoprotein; Reference proteome.
FT   CHAIN           1..838
FT                   /note="Protein FAM91A1"
FT                   /id="PRO_0000282552"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976"
FT   MOD_RES         671
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:24275569"
FT   MOD_RES         828
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         704
FT                   /note="I -> V (in dbSNP:rs6470187)"
FT                   /id="VAR_057768"
FT   VARIANT         800
FT                   /note="C -> Y (in dbSNP:rs1946586)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17974005, ECO:0000269|Ref.1"
FT                   /id="VAR_067449"
SQ   SEQUENCE   838 AA;  93909 MW;  1F50F89A4BFB6B08 CRC64;
     MNIDVEFHIR HNYPWNKLPA NVRQSLGNSQ REYEKQVVLY SIRNQLRYRN NLVKHVKKDE
     RRYYEELLKY SRDHLMLYPY HLSDIMVKGL RITPFSYYTG IMEDIMNSEK SYDSLPNFTA
     ADCLRLLGIG RNQYIDLMNQ CRSSKKFFRR KTARDLLPIK PVEIAIEAWW VVQAGYITED
     DIKICTLPEK CAVDKIIDSG PQLSGSLDYN VVHSLYNKGF IYLDVPISDD SCIAVPPLEG
     FVMNRVQGDY FETLLYKIFV SIDEHTNVAE LANVLEIDLS LVKNAVSMYC RLGFAHKKGQ
     VINLDQLHSS WKNVPSVNRL KSTLDPQKML LSWDGGESRS PVQEASSATD TDTNSQEDPA
     DTASVSSLSL STGHTKRIAF LFDSTLTAFL MMGNLSPNLK SHAVTMFEVG KLSDESLDSF
     LIELEKVQST GEGEAQRYFD HALTLRNTIL FLRHNKDLVA QTAQPDQPNY GFPLDLLRCE
     SLLGLDPATC SRVLNKNYTL LVSMAPLTNE IRPVSSCTPQ HIGPAIPEVS SVWFKLYIYH
     VTGQGPPSLL LSKGTRLRKL PDIFQSYDRL LITSWGHDPG VVPTSNVLTM LNDALTHSAV
     LIQGHGLHGI GETVHVPFPF DETELQGEFT RVNMGVHKAL QILRNRVDLQ HLCGYVTMLN
     ASSQLADRKL SDASDERGEP DLASGSDVNG STESFEMVIE EATIDSATKQ TSGATTEADW
     VPLELCFGIP LFSSELNRKV CRKIAAHGLC RKESLQNLLH SSRKLSLQVL NFVHSFQEGA
     SILDIHTEPS FSSLLSQSSC ADMGVPLPAK NLIFKDGVLS EWSGRSPSSL LIANLHLQ
//
